Open Access<p>Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib</p>
Author(s) -
Xiaoting Qiu,
Manjiang Li,
Liqun Wu,
Xinquan Yang,
Siyu Mu,
Tianxiang Li,
Kejuan Song
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s233448
Subject(s) - medicine , hepatocellular carcinoma , sorafenib , common terminology criteria for adverse events , adverse effect , pathological , gastroenterology , proportional hazards model , carcinoma , surgery
To investigate the effects of fatigue on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib.